Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $11.9 million.

  • Lemaitre Vascular's Other Operating Expenses rose 421.29% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.7 million, marking a year-over-year increase of 2090.4%. This contributed to the annual value of $46.7 million for FY2024, which is 1251.35% up from last year.
  • Lemaitre Vascular's Other Operating Expenses amounted to $11.9 million in Q3 2025, which was up 421.29% from $14.9 million recorded in Q2 2025.
  • Lemaitre Vascular's 5-year Other Operating Expenses high stood at $14.9 million for Q2 2025, and its period low was $2.6 million during Q1 2021.
  • In the last 5 years, Lemaitre Vascular's Other Operating Expenses had a median value of $11.0 million in 2024 and averaged $10.3 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first crashed by 6696.04% in 2021, then soared by 19904.76% in 2022.
  • Lemaitre Vascular's Other Operating Expenses (Quarter) stood at $6.8 million in 2021, then increased by 26.41% to $8.6 million in 2022, then increased by 19.4% to $10.3 million in 2023, then grew by 22.96% to $12.6 million in 2024, then fell by 5.57% to $11.9 million in 2025.
  • Its last three reported values are $11.9 million in Q3 2025, $14.9 million for Q2 2025, and $14.2 million during Q1 2025.